Correction to: Effect of bevacizumab on refractory meningiomas: 3D volumetric growth rate versus response assessment in neuro-oncology criteria

DOI: https://doi.org/10.1093/noajnl/vdae164

2024-10-04

Abstract:[This corrects the article DOI: 10.1093/noajnl/vdae128.].

What problem does this paper attempt to address?

Correction to: Recurrent fibroblast growth factor receptor3 fusion glioblastoma treated with pemigatinib: A case report and review of the literature

DOI: https://doi.org/10.1093/noajnl/vdae116

2024-07-08

Abstract:[This corrects the article DOI: 10.1093/noajnl/vdae072.].
Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Ru Zhou,Mahboubeh Yazdanifar,Lopamudra Das Roy,Lynsey M. Whilding,Artemis Gavrill,John Maher,Pinku Mukherjee

DOI: https://doi.org/10.3389/fimmu.2020.628776

IF: 7.3

2020-12-07

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2019.01149.].

immunology
Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab

Frontiers Production Office

DOI: https://doi.org/10.3389/fphar.2022.1092147

IF: 5.6

2022-11-22

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.973448.].

pharmacology & pharmacy
Corrigendum: Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report

Barbara Castelli,Carla Fonte,Milena Guidi,Marco Tellini,Marco Di Nicola,Alessandro Iacono,Anna Maria Buccoliero,Daniela Greto,Lorenzo Genitori,Iacopo Sardi

DOI: https://doi.org/10.3389/fonc.2024.1372295

IF: 4.7

2024-02-01

Frontiers in Oncology

Abstract:This article is a correction to: Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report

oncology
Erratum: Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI: Erratum

Junfeng Zhang,Wei Xue,Kai Xu,Liang Yi,Yu Guo,Tian Xie,Haipeng Tong,Bo Zhou,Shunan Wang,Qing Li,Heng Liu,Xiao Chen,Jingqin Fang,Weiguo Zhang

DOI: https://doi.org/10.7150/thno.92042

IF: 11.6

2023-11-17

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.44427.].
Erratum: Efficacy of Flap-based Posterior Trunk Reconstruction after Vertebrectomy and Radiation Therapy: A Retrospective Cohort Study-Erratum

DOI: https://doi.org/10.1097/GOX.0000000000005425

2023-10-18

Abstract:[This corrects the article DOI: 10.1097/GOX.0000000000005242.].
Erratum to "Additional biomarkers for pathological complete response in triple negative breast cancer"

DOI: https://doi.org/10.1177/17588359241290373

2024-10-21

Abstract:[This corrects the article DOI: 10.1177/17588359241267148.].
Corrigendum to “Angiogenesis in Pituitary Adenomas: Human Studies and New Mutant Mouse Models”

Carolina Cristina,Guillermina María Luque,Gianina Demarchi,Felicitas Lopez Vicchi,Lautaro Zubeldia-Brenner,Maria Ines Perez Millan,Sofia Perrone,Ana Maria Ornstein,Isabel M. Lacau-Mengido,Silvia Inés Berner,Damasia Becu-Villalobos

DOI: https://doi.org/10.1155/2020/8978014

2020-07-18

International Journal of Endocrinology

Abstract:[This corrects the article DOI: 10.1155/2014/608497.].

endocrinology & metabolism
Erratum: Sequential treatment escalation improves survival in patients with Waldenstrom macroglobulinemia

DOI: https://doi.org/10.1097/BS9.0000000000000185

2024-03-07

Abstract:[This corrects the article DOI: 10.1097/BS9.0000000000000179.].
Erratum: Palumbo A, Bringhen S, Mateos M-V, et al. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report. Blood. 2015;125(13):2068-2074

DOI: https://doi.org/10.1182/blood-2016-07-727081

IF: 20.3

2016-08-18

Blood

Abstract:[This corrects the article DOI: 10.1182/blood-2014-12-615187.].
Erratum: Preoperative immunological plasma markers TRAIL, CSF1, and TIE2 predict survival after resection for biliary tract cancer

Frontiers Production Office

DOI: https://doi.org/10.3389/fonc.2023.1281693

2023-09-27

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1169537.].
Erratum: First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax)

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2024.1494021

2024-09-19

Abstract:[This corrects the article DOI: 10.3389/fimmu.2024.1404861.].
Corrigendum to "Long recurrence-free survival of localized rectal melanoma after abdominoperineal resection in comparison to partial excision and highlighting the place of immunotherapy: A case report."

DOI: https://doi.org/10.1177/20542704241260192

2024-06-02

JRSM Open

Abstract:[This corrects the article DOI: 10.1177/20542704221148059.].
Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma

Fangling Cheng,Po Zhang,Qungen Xiao,Youwei Li,Minhai Dong,Heping Wang,Dong Kuang,Yue He,Qiuhong Duan,Feng Mao,Baofeng Wang,Dongsheng Guo

DOI: https://doi.org/10.3389/fonc.2020.591112

2020-09-25

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.00447.].
Correction to: Primary gliosarcoma: epidemiology, clinical presentation, management, and survival

Ruichong Ma,Delia-Marina Alexe,Erlick A Pereira

DOI: https://doi.org/10.23736/S0390-5616.20.05218-2

Abstract:This corrects the article DOI: 10.23736/S0390-5616.17.04077-2.
Correction: A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11

Hironaga Satake,Yu Sunakawa,Yuji Miyamoto,Masato Nakamura,Hiroshi Nakayama,Manabu Shiozawa,Akitaka Makiyama,Kazuma Kobayashi,Yutaro Kubota,Misuzu Mori,Masahito Kotaka,Akinori Takagane,Masahiro Gotoh,Masahiro Takeuchi,Masashi Fujii,Wataru Ichikawa,Takashi Sekikawa

DOI: https://doi.org/10.18632/oncotarget.25775

2018-07-06

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.24702.].
Erratum: Genetic Predisposition to Numerous Large Ulcerating Basal Cell Carcinomas and Response to Immune Therapy: Erratum

DOI: https://doi.org/10.1097/JD9.0000000000000184

Abstract:[This corrects the article DOI: 10.1097/JD9.0000000000000170.].
Corrigendum: Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice

Longsha Liu,Thijs A van Schaik,Kok-Siong Chen,Filippo Rossignoli,Paulo Borges,Vladimir Vrbanac,Hiroaki Wakimoto,Khalid Shah

DOI: https://doi.org/10.3389/fimmu.2024.1466387

2024-08-05

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1324618.].
Corrigendum: the Visual Acuity Outcome and Relevant Factors Affecting Visual Improvement in Pediatric Sporadic Chiasmatic–Hypothalamic Glioma Patients Who Received Surgery

Chihyi Liao,Heng Zhang,Zhiming Liu,Zhe Han,Chunde Li,Jian Gong,Wei Liu,Zhenyu Ma,Yongji Tian

DOI: https://doi.org/10.3389/fneur.2022.914268

IF: 3.4

2022-01-01

Frontiers in Neurology

Abstract:[This corrects the article DOI: 10.3389/fneur.2020.00766.].
Correction to: The Effect of Postmastectomy Radiotherapy on Breast Cancer Patients After Neoadjuvant Chemotherapy by Molecular Subtype

Jia-Chun Ma,Xiao-Rong Zhong,Ting Luo,Zhong-Zheng Xiang,Jia-Yuan Li,Chuanxu Luo,Xi Yan,Ping He,Ting-Lun Tian,Fang Liu,Lei Liu,Hong Zheng

DOI: https://doi.org/10.1245/s10434-021-09771-9

IF: 4.339

2021-02-26

Annals of Surgical Oncology

Abstract:A correction to this paper has been published: https://doi.org/10.1245/s10434-021-09771-9

oncology,surgery

Correction to: Effect of bevacizumab on refractory meningiomas: 3D volumetric growth rate versus response assessment in neuro-oncology criteria

Correction to: Recurrent fibroblast growth factor receptor3 fusion glioblastoma treated with pemigatinib: A case report and review of the literature

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab

Corrigendum: Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report

Erratum: Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI: Erratum

Erratum: Efficacy of Flap-based Posterior Trunk Reconstruction after Vertebrectomy and Radiation Therapy: A Retrospective Cohort Study-Erratum

Erratum to "Additional biomarkers for pathological complete response in triple negative breast cancer"

Corrigendum to “Angiogenesis in Pituitary Adenomas: Human Studies and New Mutant Mouse Models”

Erratum: Sequential treatment escalation improves survival in patients with Waldenstrom macroglobulinemia

Erratum: Palumbo A, Bringhen S, Mateos M-V, et al. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report. Blood. 2015;125(13):2068-2074

Erratum: Preoperative immunological plasma markers TRAIL, CSF1, and TIE2 predict survival after resection for biliary tract cancer

Erratum: First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax)

Corrigendum to "Long recurrence-free survival of localized rectal melanoma after abdominoperineal resection in comparison to partial excision and highlighting the place of immunotherapy: A case report."

Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma

Correction to: Primary gliosarcoma: epidemiology, clinical presentation, management, and survival

Correction: A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11

Erratum: Genetic Predisposition to Numerous Large Ulcerating Basal Cell Carcinomas and Response to Immune Therapy: Erratum

Corrigendum: Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice

Corrigendum: the Visual Acuity Outcome and Relevant Factors Affecting Visual Improvement in Pediatric Sporadic Chiasmatic–Hypothalamic Glioma Patients Who Received Surgery

Correction to: The Effect of Postmastectomy Radiotherapy on Breast Cancer Patients After Neoadjuvant Chemotherapy by Molecular Subtype